![]()
For many people struggling with obesity and weight gain, drugs like Ozempic have felt like a breakthrough moment. Weight drops steadily, appetite quietens, and for the first time in years, the scales seem to cooperate. Social media is full of before-and-after photos, success stories, and glowing testimonials.
But under the hype, scientists have been researching what happens when the injections stop?
Though there have been a number of studies on this, a new research published by The BMJ reaffirms what we've known for some time now: That while these medications can trigger rapid weight loss, the benefits often unravel soon after treatment ends.
Researchers found that people regain weight faster after stopping these drugs than they do after traditional diet and exercise programmes, and many of the health gains disappear just as quickly.
Also read | Ozempic and Semaglutide: Dietitian explains everything you should know about weight loss drugs
The weight is back
The analysis, led by researchers at the University of Oxford, reviewed 37 studies involving more than 9,000 adults who used prescription weight loss medications. On average, participants regained around 0.4 kg every month after stopping treatment. At that pace, most people were projected to return to their original weight in under two years.
Even more striking was how fast the rebound happened compared with exercise-based weight loss. Those who lost weight through diet and physical activity regained it far more slowly. The difference was stark: Weight regained after medication was nearly four times faster, regardless of how much weight was lost in the first place.
Health benefits also fade
The concern is not just cosmetic. Improvements in blood pressure, cholesterol, and markers linked to diabetes also tended to reverse after treatment ended. Researchers estimated that heart and metabolic risk levels would return to pre-treatment levels in around 18 months.
This matters because many people turn to GLP-1 drugs not just to lose weight, but to protect their long-term health. If those benefits fade so quickly, the promise of these medications becomes far more complicated.
Also read | Diabetes drug Ozempic is good not just for weight loss, study claims it even protects brain
About half of people prescribed GLP-1 drugs stop taking them within a year, often due to side effects, cost, or access issues. That makes understanding life after the medication especially urgent.
What the study says
Rapid rebound: Weight regain begins almost immediately after stopping treatment
Health reversals: Heart and metabolic improvements often fade within two years
Faster than lifestyle regain: Weight returns much quicker than after diet-only loss
Limited long-term data: Few studies track patients beyond 12 months post-treatment
Medication isn’t enough: Lasting success likely needs diet, movement, and prevention
Researchers stress that these findings do not mean weight loss drugs are useless. Instead, they highlight their limits. Experts argue that GLP-1 medications work best as a support tool, not a standalone solution.
Hence, there is no magic jab for obesity. Real, durable change still depends on long-term habits, prevention, and realistic expectations. The drugs may open the door, but staying healthy means walking through it without relying on injections alone.
Disclaimer: This article, including health and fitness advice, only provides generic information. Don’t treat it as a substitute for qualified medical opinion. Always consult a specialist for specific health diagnosis.